Navigation Links
Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
Date:12/10/2009

diabetes care, and has refocused its efforts in this important therapeutic area with the creation of a diabetes business unit that includes a dedicated asset base and a portfolio of commercially-successful products and promising pipeline opportunities. Lilly is one of only a few companies positioned to compete globally in the insulins business. The company remains firmly committed to its insulins franchise and is making the investments necessary in key geographies to further strengthen its competitive position. In addition, Lilly intends to maintain a leading role in the rapidly emerging area of GLP-based therapy. The need for new and improved treatments for patients with diabetes is great: an estimated 285 million people are expected to be affected worldwide in 2010.

Humalog® sales for the first three quarters of 2009 have grown 12 percent worldwide, including 21 percent growth in the U.S. market. Humalog has continued to show growth in total prescriptions in the U.S. over the past year. In addition, the company continues to launch its flagship pre-filled pen, Humalog KwikPen(TM), in markets around the world, and will continue to do so in 2010.

Byetta® remains the first and only GLP-1 receptor agonist available in the U.S. market. Since the initial effects of last year's FDA safety alert on Byetta's U.S. performance, the company and its partner, Amylin Pharmaceuticals, have slowed the erosion of prescriptions and are focused on returning Byetta to growth. Internationally, Byetta has been launched in approximately 60 countries, including most major markets. The company is pleased with the uptake of Byetta in many markets, including the major five European markets. Byetta was recently launched in China and is under regulatory review in Canada and Japan.

Key molecules in the diabetes business unit pipeline include:

  • Exenatide once weekly - The company continues to develop exenatide once weekly with
    '/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Advanced Wound Dressings - ... Advanced dressings have steadily replaced traditional bandages and ... of wound indications, such as trauma wounds, burns, ... and physical protection become increasingly critical in wound ... standard therapy. This report focuses on nine ...
(Date:9/2/2015)... PHILADELPHIA, Pa. , Sept. 2, 2015 /PRNewswire/ ... Substantially increases, diversifies revenue base with highly profitable ... products , Near-term growth potential with 11 ... five include Paragraph IV certifications  , Provides ... product candidates in development, including eight controlled substances ...
(Date:9/2/2015)... 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ... Drug Delivery (London, UK - November 19-20, 2015)" ... Delivery meeting will cover industry case studies, regulatory updates, ... Co-Chairmen are Dr Steven Nichols , OINP Specialist ... Companies participating include: ...
Breaking Medicine Technology:Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6
... SeqWright Inc., an international leader in the field ... Hologic,s (formerly Third Wave Technologies) successful clinical trials of ... tests. SeqWright provided FDA submission quality DNA sequencing ... two Hologic HPV diagnostic tests; Cervista HPV ...
... Application to Expand the NUVIGIL(R) Label , FRAZER, Pa., ... CEPH ) today announced positive results from a ... as a treatment for excessive sleepiness associated with jet ... file a supplemental New Drug Application with the U.S. ...
Cached Medicine Technology:SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4
(Date:9/3/2015)... , ... September 03, 2015 , ... ... that Bob Anders and Kelley Chapman will be joining the company’s executive leadership ... , Anders has over 30 years’ experience in healthcare product and project management. ...
(Date:9/2/2015)... ... ... Leah Binder, MA, MGA, president and CEO of The ... offer the keynote address at the upcoming meeting of the ACO and Emerging ... at the Innisbrook Resort and Golf Club. For an agenda and registration, visit ...
(Date:9/2/2015)... ... 02, 2015 , ... Chris Harrison of Harrison’s Footwear of Poulsbo announces the ... really,” says Chris. “We have a lot of repeat customers, and many of them ... for them—so we’ve given them the convenience of ordering from home.” , Harrison’s Footwear ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Telehealth represents ... Well Corp., contracted to handle the telehealth services of more than 12 Blues plan ... and Blue Shield Plans takes a look this growing trend, interviewing executives at Capital ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... data collection, cloud analytics and workflow solutions today announced the September 2015 ... researchers to participate in interactive programs in which ERT scientists and partner ...
Breaking Medicine News(10 mins):Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
... scientists say , , WEDNESDAY, Sept. 5 (HealthDay News) -- Two ... of them also increases the odds for lupus, according to ... the gene called STAT4 is one of the ... rheumatoid arthritis or lupus, both of which are autoimmune disorders, ...
... While it,s a relatively new,function, Competitive Intelligence ... in the marketplace. By delivering high-impact,analyses on competitors, ... companies to emerging market opportunities or warn them,about ... an average of 60 products sold by,competitors, according ...
... Congress to Increase Federal Funding for Deadly,Incurable Disease, ... Fibrosis (CPF) is launching an advertising campaign aimed at,Members ... Week Sept.,22-29, 2007., The campaign, which includes both ... and urge Members of Congress to take action to ...
... environmental stress contributes to cardiovascular disease and type II ... Georgia. , The study, which follows 523 pairs of ... from the National Institutes of Health. , Cardiovascular ... an important health challenge to the United States, says ...
... Fla., Sept. 5 Your child has been,playing outside. His ... before,dinner. It,s a nightly ritual in millions of homes all ... But hand washing isn,t just about dirt. The U.S. Centers ... the most important,things children can do to help stay healthy. ...
... The Governing Board,of Texas Medical Liability Trust (TMLT) ... TMLT policyholders. The Board has,approved a 6.5% rate ... 1, 2008. In addition, all current TMLT policyholders,renewing ... equal to 22% of,their expiring premium. The total ...
Cached Medicine News:Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 4Health News:New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group 2Health News:Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress 2Health News:Environmental stress probed in cardiovascular disease, diabetes 2Health News:When Should Children Wash Their Hands? 2Health News:Texas' Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: